A big operation through a small, self-sealing door

Phacoemulsification emulsifies the lens with an ultrasonic probe through a tiny incision — brilliant, but dependent on a costly machine, disposable tips and reliable power. MSICS takes a different route: a carefully constructed scleral tunnel, funnel-shaped so that the eye's own pressure presses it shut. Through it the surgeon delivers the nucleus, cleans the bag, and implants the lens — and the wound seals without a single suture.

The genius is in the tunnel architecture. Done well, it is watertight, astigmatism-neutral and fast. Done across a camp day, it lets one surgeon restore sight to fifty people who would otherwise wait years^[5].

What the trials actually show

MSICS is not a compromise technique for the poor. It is an evidence-backed operation. Head-to-head randomised controlled trials have compared it directly with phacoemulsification^[1][2].

Technique choice is always the surgeon's clinical decision, case by case. Many high-volume surgeons use both — phaco for softer cataracts, MSICS for dense ones and for maximum throughput.

The technique is free; the consumables are not

MSICS democratised the skill of cataract surgery. But a flawless tunnel still fails without the small tray of consumables that make each step safe.

A capsule stain turns an invisible anterior capsule blue so the surgeon can complete a controlled capsulorhexis in a dense white cataract. A viscoelastic keeps the chamber formed and shields the corneal endothelium during nucleus delivery — the single most important protection against corneal decompensation. An intraocular lens finishes the case. And an intracameral antibiotic at closure sharply reduces the risk of endophthalmitis, the rare infection every programme fears^[3]. Get these consumables cheap and consistent, and MSICS becomes the most cost-effective sight-restoring operation on earth.

Why a sutureless wound holds

The whole operation rests on one piece of engineering: the scleral tunnel. Understanding its geometry explains why MSICS is both safe and fast.

The surgeon begins with an external scleral incision a few millimetres behind the limbus, then dissects forward in a single plane to create a tunnel that enters the anterior chamber through clear cornea. The key is the shape: the internal opening is made wider than the external one — a funnel, or frown, configuration. When the eye is pressurised, aqueous pushes the roof of the tunnel down against its floor, and the mismatch in width means internal pressure seals the wound rather than opening it. This is the same valve principle that lets the wound stay watertight without a single stitch.

Because the tunnel is self-sealing, MSICS avoids suture-induced astigmatism — a major historical drawback of older large-incision extracapsular surgery. And because the nucleus is delivered through this tunnel rather than emulsified in place, the technique handles rock-hard, mature, 'brunescent' cataracts that can defeat or dramatically lengthen a phaco case. In regions where patients present late — often only when the second eye also blinds them — that ability to deal with dense cataracts is not a niche advantage; it is the main event.

What the randomised trials found

The comparison with phacoemulsification has been tested directly, not asserted. In the large randomised trials, both techniques delivered excellent corrected vision: well over 90% of eyes in each arm achieved 6/18 or better best-corrected acuity^[1][2]. Phaco held a modest edge in uncorrected vision in the early post-operative period, largely because of tighter control of surgically induced astigmatism; by best-corrected acuity, the two were statistically comparable.

Where MSICS pulled ahead was speed and cost. Operative times were shorter, and the per-case cost was a fraction of phaco once machine and disposable-tip costs were counted. For a system trying to raise its Cataract Surgical Rate, that combination — comparable outcomes, higher throughput, lower cost — is decisive. It is precisely why MSICS became the backbone of high-volume charitable and public surgery rather than a second-best fallback^[5].

Endothelium, viscoelastic & the soft-shell

The corneal endothelium is a single, non-regenerating layer of cells that keeps the cornea clear by pumping out fluid. Every cataract operation costs some of those cells; lose too many and the cornea swells and clouds — a devastating outcome after successful cataract removal. Typical endothelial cell loss in modern cataract surgery runs in the single-digit-to-low-teens percent range, and viscoelastic technique is the main lever on where you land in that range.

This is why the OVD is not a commodity. A dispersive viscoelastic coating the endothelium during nucleus delivery physically shields those cells from turbulence and lens fragments; a cohesive OVD keeps the chamber deep so instruments never chatter against the cornea. The 'soft-shell' technique layers both for maximum protection. A poor-quality or inconsistent OVD undermines exactly this protection — which is how a cheap-but-bad viscoelastic turns into the most expensive item in the theatre, paid for in corneal decompensations weeks later.

Endophthalmitis & intracameral prophylaxis

Post-operative endophthalmitis — infection inside the eye — is rare but sight-destroying, and it is the complication that keeps high-volume surgeons awake. The landmark ESCRS multicentre randomised study established that an intracameral antibiotic injected into the anterior chamber at the close of surgery reduces the rate of endophthalmitis roughly fivefold compared with no intracameral prophylaxis^[3].

For a programme performing tens of thousands of surgeries a year, a fivefold reduction is not a statistic — it is dozens of eyes saved from blindness annually. Intracameral moxifloxacin has become a widely used option because it is well tolerated in the anterior chamber and broad-spectrum. Building it into the standard tray, at an affordable price, is one of the highest-leverage safety decisions a high-volume service can make.

References & peer-reviewed sources

The solutions behind the surgery

The consumables MSICS runs on — capsule stain, endothelium-protecting viscoelastics, IOLs and intracameral prophylaxis — engineered for consistency on high-volume camp and theatre days.

Explore the full range on the Agaaz product portfolio.